Infliximab induction and maintenance therapy for ulcerative colitis: the act 2 trial

被引：0
|
作者：
Sandborn, WJ
Rachmilewitz, D
Hanauer, SB
Lichtenstein, GR
de Villiers, WJ
Olson, A
Johanns, J
Travers, S
Colombel, JF
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A36 / A36
页数：1
相关论文
共 50 条
  • [31] Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
    Vermeire, Severine
    O'Byrne, Sharon
    Keir, Mary
    Williams, Marna
    Lu, Timothy T.
    Mansfield, John C.
    Lamb, Christopher A.
    Feagan, Brian G.
    Panes, Julian
    Salas, Azucena
    Baumgart, Daniel C.
    Schreiber, Stefan
    Dotan, Iris
    Sandborn, William J.
    Tew, Gaik W.
    Luca, Diana
    Tang, Meina T.
    Diehl, Lauri
    Eastham-Anderson, Jeffrey
    De Hertogh, Gert
    Perrier, Clementine
    Egen, Jackson G.
    Kirby, John A.
    van Assche, Gert
    Rutgeerts, Paul
    LANCET, 2014, 384 (9940): : 309 - 318
  • [32] A randomized placebo-controlled trial of infliximab therapy for active ulcerative colitis: ACT 1 trial results through week 54
    Sandborn, WJ
    Feagan, BG
    Olson, A
    Johanns, J
    Travers, S
    Present, D
    Sands, BE
    Rutgeerts, P
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S313 - S313
  • [33] Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis
    Seah, Dean
    Choy, Matthew C.
    Gorelik, Alexandra
    Connell, William R.
    Sparrow, Miles P.
    Van Langenberg, Daniel
    Hebbard, Geoffrey
    Moore, Gregory
    De Cruz, Peter
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (01) : 226 - 231
  • [34] Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England
    Russo, E. A.
    Harris, A. W.
    Campbell, S.
    Lindsay, J.
    Hart, A.
    Arebi, N.
    Milestone, A.
    Tsai, H. H.
    Walters, J.
    Carpani, M.
    Westaby, D.
    Thillainayagam, A.
    Bansi, D.
    Ghosh, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (03) : 308 - 314
  • [35] Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis
    Seah, D.
    Choy, M.
    Gorelik, A.
    Macrae, F.
    Sparrow, M.
    Connell, W. R.
    Moore, G.
    Van Langenberg, D.
    De Cruz, P.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S275 - S276
  • [36] Systematic review:: infliximab therapy in ulcerative colitis
    Gisbert, J. P.
    Gonzalez-Lama, Y.
    Mate, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (01) : 19 - 37
  • [37] Efficacy of infliximab therapy for severe ulcerative colitis
    Seow, C.
    Silverberg, M.
    Newman, A.
    Steinhart, H.
    Greenberg, G.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S25 - S25
  • [38] Infliximab as a novel therapy for pediatric ulcerative colitis
    Mamula, P
    Markowitz, JE
    Brown, KA
    Hurd, LB
    Piccoli, DA
    Baldassano, RN
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002, 34 (03): : 307 - 311
  • [39] Optimising infliximab induction dosing for patients with ulcerative colitis
    Dreesen, Erwin
    Faelens, Ruben
    Van Assche, Gert
    Ferrante, Marc
    Vermeire, Severine
    Gils, Ann
    Bouillon, Thomas
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (04) : 782 - 795
  • [40] Is infliximab effective for induction of remission in patients with ulcerative colitis?
    Lichtenstein, GR
    INFLAMMATORY BOWEL DISEASES, 2001, 7 (02) : 89 - 93
12345